A 55-year-old patient with newly diagnosed hypertension is being considered for antihypertensive therapy. A randomized controlled trial demonstrates a relative risk reduction of 30% in stroke with the new drug compared to placebo over 5 years. The absolute risk reduction is 1.5%. Which measure best communicates the number of patients that need to be treated to prevent one additional stroke?